Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Hitting Home Runs & Grand Slams, Not Loud Outs
- RTI: Do Stocks Tank When QE Ends?
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Aggressive Growth Stocks
- Who Wants to Keep "Too Big to Fail" Alive?
- Debt-Ceiling Alarm Bell Tolls
- Avoid These 3 Eurozone ETFs This Summer
- RTI: When Will We Finally See a Pullback?
- Top Stocks with Big Potential Catch-Up Moves
- AWS 5/22: Will Bernanke Show His Hand?
- PFP 5/22: Singular Stock Focus Continues
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/22/2013
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 9.31% |
| SONIC FOUNDR | SOFO | 7.77% |
| VELTI PLC OR | VELT | 7.58% |
| TRI TECH HOL | TRIT | 6.62% |
| A M R CP | AAMRQ | 4.52% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
•Bed Bath & Beyond Inc.’s (NASDAQ:BBBY) shares rose 10.5% a day after the retailer projected earnings ahead of Wall Street’s expectations for the fiscal year ending in Feb. 2012
•Drug developer Immunogen Inc. (NASDAQ:IMGN) reported positive results from a mid-stage study of its breast-cancer treatment
•Home-furnishing retailer Pier 1 Imports Inc (NYSE:PIR) reported better-than-expected profit and sales for the fourth quarter and announced plans to buy back up to $100 million in stock
•Late Wednesday, XenoPort Inc. (NASDAQ:XNPT) and GlaxoSmithKline PLC ( GSK - Analyst Report ) announced that they had received regulatory approval for a drug to treat restless-legs syndrome
•Citigroup analysts added semiconductor equipment maker, Lam Research Corp (NASDAQ:LRCX) to the brokerage’s conviction sell list
•Wine and spirits maker Constellation Brands (NYSE:STZ) forecasts its full-year profit above the Street's view and announced a new stock buyback program
•According to reports, investors may be betting that Coinstar, (NASDAQ:CSTR) the new owners of Blockbuster will close some locations which acts as a positive news for the company’s redbox DVD kiosks
•FBR Capital upgraded salesforce.com, inc (NYSE:CRM) to ‘Outperform’ from ‘Market Perform’ and raised the target price to $170 from $155
Read the full Analyst Report on BBBY
Read the full Snapshot Report on IMGN
Read the full Snapshot Report on PIR
Read the full Snapshot Report on XNPT
Read the full Analyst Report on GSK
Read the full Snapshot Report on LRCX
Read the full Analyst Report on STZ
Read the full Snapshot Report on CSTR
Read the full Analyst Report on CRM